Notice: This company has been marked as potentially delisted and may not be actively trading. XTL Biopharmaceuticals (XTLB) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisCompetitorsEarningsHeadlinesShort InterestTrends XTL Biopharmaceuticals Short Interest DataXTL Biopharmaceuticals (XTLB) has a short interest of 75,000 shares. This marks a -0.27% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.9, indicating that it would take 1.9 days of the average trading volume of 11,894 shares to cover all short positions.Current Short Interest75,000 sharesPrevious Short Interest75,200 sharesChange Vs. Previous Month-0.27%Dollar Volume Sold Short$141,000.00Short Interest Ratio1.9 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares5,450,000 sharesPercentage of Shares Shorted1.38%Today's Trading Volume15,652 sharesAverage Trading Volume11,894 sharesToday's Volume Vs. Average132% Short Selling XTL Biopharmaceuticals? Sign up to receive the latest short interest report for XTL Biopharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartXTLB Short Interest Over TimeXTLB Days to Cover Over TimeXTLB Percentage of Float Shorted Over Time Ad Huge AlertsUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Click here to see how this opportunity could transform your portfolio. XTL Biopharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202475,000 shares $141,000.00 -0.3%N/A1.9 $1.88 11/15/202475,200 shares $138,368.00 -64.8%N/A1.9 $1.84 10/31/2024213,400 shares $475,882.00 +2,381.4%N/A5.4 $2.23 10/15/20248,600 shares $19,092.00 -41.5%N/A1 $2.22 9/30/202414,700 shares $35,574.00 +51.6%N/A1.4 $2.42 9/15/20249,700 shares $25,501.30 +1.0%N/A0.9 $2.63 Get the Latest News and Ratings for XTLB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for XTL Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/20249,600 shares $26,784.00 -7.7%N/A0.6 $2.79 8/15/202410,400 shares $29,016.00 +103.9%N/A0.6 $2.79 7/31/20245,100 shares $14,688.00 -64.3%N/A0.3 $2.88 7/15/202414,300 shares $35,607.00 -19.2%N/A0.8 $2.49 6/30/202417,700 shares $43,011.00 +78.8%N/A0.8 $2.43 6/15/20249,900 shares $20,196.00 -55.0%N/A0 $2.04 5/31/202422,000 shares $57,200.00 -13.4%N/A0 $2.60 5/15/202425,400 shares $69,596.00 +13.4%N/A0 $2.74 4/30/202422,400 shares $57,792.00 -62.8%N/A0 $2.58 4/15/202460,200 shares $161,336.00 -86.2%N/A0.1 $2.68 3/31/2024437,200 shares $1.23 million +21,760.0%N/A0.6 $2.81 3/15/20242,000 shares $1,760.00 +11.1%N/A0 $0.88 2/29/20241,800 shares $1,531.26 -37.9%N/A0.6 $0.85 2/15/20242,900 shares $2,608.26 -42.0%N/A0.9 $0.90 1/31/20245,000 shares $4,378.50 -27.5%N/A1.4 $0.88 1/15/20246,900 shares $6,009.90 +1.5%N/A1.9 $0.87 12/31/20236,800 shares $6,868.68 -32.7%N/A1.7 $1.01 12/15/202310,100 shares $9,965.67 -15.8%N/A3.9 $0.99 11/30/202312,000 shares $12,360.00 +36.4%N/A5.7 $1.03 11/15/20238,800 shares $6,864.00 -24.8%N/A2.7 $0.78 10/31/202311,700 shares $10,148.58 +62.5%N/A3.2 $0.87 10/15/20237,200 shares $6,480.00 -22.6%N/A1.3 $0.90 9/30/20239,300 shares $8,347.68 -3.1%N/A1.7 $0.90 9/15/20239,600 shares $9,311.04 +29.7%N/A1.5 $0.97 8/31/20237,400 shares $7,770.00 +236.4%N/A0.5 $1.05 8/15/20232,200 shares $2,086.26 +29.4%N/A0.2 $0.95 7/31/20231,700 shares $1,385.84 -19.1%N/A0.1 $0.82 7/15/20232,100 shares $2,142.00 -16.0%N/A0.1 $1.02 6/30/20232,500 shares $2,376.75 -28.6%N/A0.2 $0.95 6/15/20233,500 shares $4,620.00 -25.5%N/A0.2 $1.32 5/31/20234,700 shares $5,734.00 +27.0%N/A0.6 $1.22 5/15/20233,700 shares $4,477.00 +23.3%N/A0.5 $1.21 4/30/20233,000 shares $3,360.00 -55.2%N/A0.5 $1.12 4/15/20236,700 shares $8,241.00 -23.0%N/A1.7 $1.23Healthcare Takes A Big Step Forward With The Help of A.I. (Ad)To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems. For its next act, AI is going to help save lives. Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare.Click here to learn more about the booming eHealth industry - and see which microcap will be at the 3/31/20238,700 shares $11,049.00 +117.5%N/A4.1 $1.27 3/15/20234,000 shares $4,920.00 +2.6%N/A1.6 $1.23 2/28/20233,900 shares $5,459.61 -7.1%N/A1.3 $1.40 2/15/20234,200 shares $5,586.00 -16.0%N/A1.5 $1.33 1/31/20235,000 shares $5,850.00 -12.3%N/A1.4 $1.17 1/15/20235,700 shares $7,866.00 +2,750.0%N/A1.7 $1.38 12/30/2022200 shares $242.00 -95.7%N/A0.1 $1.21 12/15/20224,700 shares $5,687.00 -6.0%N/A1 $1.21 11/30/20225,000 shares $6,650.00 +6.4%N/A1.2 $1.33 11/15/20224,700 shares $6,674.00 +261.5%N/A1 $1.42 10/31/20221,300 shares $1,677.00 -40.9%N/A0.3 $1.29 10/15/20222,200 shares $2,651.00 +83.3%N/A0.3 $1.21 9/30/20221,200 shares $1,332.00 -77.4%N/A0.2 $1.11 9/15/20225,300 shares $7,155.00 -22.1%N/A0.9 $1.35 8/31/20226,800 shares $10,064.00 +4.6%N/A1.2 $1.48 8/15/20226,500 shares $11,115.00 +8.3%N/A1.2 $1.71 7/31/20226,000 shares $9,780.00 -25.9%N/A1.1 $1.63 7/15/20228,100 shares $12,231.00 +42.1%N/A2.9 $1.51 6/30/20225,700 shares $8,664.00 +11.8%N/A1.7 $1.52 6/15/20225,100 shares $7,854.00 -13.6%N/A1.5 $1.54 5/31/20225,900 shares $10,714.99 -37.2%N/A0.9 $1.82 5/15/20229,400 shares $15,886.00 +20.5%N/A1.5 $1.69 4/30/20227,800 shares $17,160.00 +9.9%N/A1.4 $2.20 4/15/20227,100 shares $16,685.00 +16.4%N/A1.2 $2.35 3/31/20226,100 shares $14,457.00 +96.8%N/A0.9 $2.37 3/15/20223,100 shares $6,616.95 +121.4%N/A0.3 $2.13 2/28/20221,400 shares $3,332.00 -17.7%N/A0.1 $2.38 2/15/20221,700 shares $4,114.00 No ChangeN/A0.1 $2.42 1/31/20221,700 shares $4,284.00 -56.4%N/A0.1 $2.52 1/15/20223,900 shares $11,349.00 -17.0%N/A0.1 $2.91 12/31/20214,700 shares $13,019.00 +147.4%N/A0.2 $2.77 12/15/20211,900 shares $5,567.00 -64.2%N/A0.1 $2.93 11/30/20215,300 shares $16,960.00 +960.0%N/A0.2 $3.20 11/15/2021500 shares $1,790.00 -58.3%N/A0 $3.58 10/29/20211,200 shares $4,584.00 -60.0%N/A0 $3.82 10/15/20213,000 shares $11,790.00 -85.2%N/A0 $3.93 9/30/202120,200 shares $88,476.00 +1.0%N/A0.1 $4.38 9/15/202120,000 shares $82,800.00 -68.7%N/A0.1 $4.14 8/31/202163,900 shares $316,305.00 +75.6%N/A0.4 $4.95 8/13/202136,400 shares $129,220.00 -15.7%N/A0.3 $3.55 7/30/202143,200 shares $151,200.00 +37.6%N/A0.5 $3.50 7/15/202131,400 shares $108,958.00 -35.3%N/A0.4 $3.47 6/30/202148,500 shares $193,515.00 +40.2%N/A3.4 $3.99 6/15/202134,600 shares $119,370.00 -2.8%N/A2.1 $3.45 5/28/202135,600 shares $125,682.24 +14.8%N/A1.5 $3.53 5/14/202131,000 shares $103,230.00 -19.7%N/A0.1 $3.33 4/30/202138,600 shares $137,416.00 -5.6%N/A0.1 $3.56 4/15/202140,900 shares $132,516.00 -1.2%N/A0.2 $3.24 3/31/202141,400 shares $136,206.00 -19.8%N/A0.2 $3.29 3/15/202151,600 shares $174,924.00 +719.1%N/A0.2 $3.39Healthcare Takes A Big Step Forward With The Help of A.I. (Ad)To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems. For its next act, AI is going to help save lives. Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare.Click here to learn more about the booming eHealth industry - and see which microcap will be at the 2/26/20216,300 shares $19,152.00 -77.7%N/A0 $3.04 2/12/202128,200 shares $106,596.00 +464.0%N/A1 $3.78 1/29/20215,000 shares $16,100.00 -76.5%N/A0.2 $3.22 1/15/202121,300 shares $84,135.00 +88.5%N/A0.8 $3.95 12/31/202011,300 shares $35,764.50 -76.6%N/A0.4 $3.17 12/15/202048,200 shares $126,766.00 +518.0%N/A2.5 $2.63 11/30/20207,800 shares $19,573.32 -34.5%N/A0.5 $2.51 10/30/20206,900 shares $15,318.00 -46.1%N/A0.4 $2.22 10/15/202012,800 shares $27,904.00 -14.1%N/A0.7 $2.18 9/30/202014,900 shares $28,308.51 +156.9%N/A0.9 $1.90 9/15/20205,800 shares $12,586.00 +65.7%N/A0.3 $2.17 8/31/20203,500 shares $5,950.00 +483.3%N/A0.1 $1.70 8/14/2020600 shares $1,032.00 -45.5%N/A0 $1.72 7/31/20201,100 shares $1,732.50 -93.3%N/A0.1 $1.58 7/15/202016,400 shares $25,060.84 +198.2%N/A0.9 $1.53 6/30/20205,500 shares $8,525.00 -16.7%N/A0.3 $1.55 6/15/20206,600 shares $9,075.00 -7.0%N/A0.4 $1.38 5/29/20207,100 shares $9,744.75 -47.0%N/A2.1 $1.37 5/15/202013,400 shares $18,626.00 -19.3%N/A2.7 $1.39 4/30/202016,600 shares $20,160.70 -3.5%N/A2.8 $1.21 4/15/202017,200 shares $19,780.00 -1.7%N/A2.4 $1.15 3/31/202017,500 shares $20,562.50 +10.1%N/A2 $1.18 3/13/202015,900 shares $16,536.00 +1.9%N/A1.7 $1.04 2/28/202015,600 shares $15,600.00 -7.7%N/A1.4 $1.00 2/14/202016,900 shares $18,083.00 -17.6%N/A1.8 $1.07 1/31/202020,500 shares $28,700.00 -3.3%N/A2.6 $1.40 1/15/202021,200 shares $30,740.00 +40.4%N/A3.5 $1.45 12/31/201915,100 shares $19,781.00 No ChangeN/A2.7 $1.31 XTLB Short Interest - Frequently Asked Questions What is XTL Biopharmaceuticals' current short interest? Short interest is the volume of XTL Biopharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 75,000 shares of XTLB short. Learn More on XTL Biopharmaceuticals' current short interest. What is a good short interest ratio for XTL Biopharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XTLB shares currently have a short interest ratio of 2.0. Learn More on XTL Biopharmaceuticals's short interest ratio. Is XTL Biopharmaceuticals' short interest increasing or decreasing? XTL Biopharmaceuticals saw a decline in short interest during the month of November. As of November 30th, there was short interest totaling 75,000 shares, a decline of 0.3% from the previous total of 75,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does XTL Biopharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to XTL Biopharmaceuticals: Tempest Therapeutics, Inc. (6.72%), Affimed (4.70%), Anebulo Pharmaceuticals, Inc. (0.07%), Incannex Healthcare Inc. (0.21%), FibroGen, Inc. (3.41%), Verrica Pharmaceuticals Inc. (6.67%), RAPT Therapeutics, Inc. (3.92%), RenovoRx, Inc. (0.38%), ProMIS Neurosciences, Inc. (0.70%), Cumberland Pharmaceuticals Inc. (2.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short XTL Biopharmaceuticals stock? Short selling XTLB is an investing strategy that aims to generate trading profit from XTL Biopharmaceuticals as its price is falling. XTLB shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against XTL Biopharmaceuticals? A short squeeze for XTL Biopharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of XTLB, which in turn drives the price of the stock up even further. How often is XTL Biopharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XTLB, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Tempest Therapeutics Short Squeeze Affimed Short Squeeze Anebulo Pharmaceuticals Short Squeeze Incannex Healthcare Short Squeeze FibroGen Short Squeeze Verrica Pharmaceuticals Short Squeeze RAPT Therapeutics Short Squeeze RenovoRx Short Squeeze ProMIS Neurosciences Short Squeeze Cumberland Pharmaceuticals Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XTLB) was last updated on 12/19/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XTL Biopharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share XTL Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.